Paloma Partners Management Co purchased a new position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 2,500 shares of the semiconductor company’s stock, valued at approximately $1,213,000.
Several other large investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in Synopsys by 0.8% during the fourth quarter. Vanguard Group Inc. now owns 14,482,776 shares of the semiconductor company’s stock worth $7,029,360,000 after purchasing an additional 120,575 shares in the last quarter. Capital World Investors raised its holdings in Synopsys by 1.6% during the fourth quarter. Capital World Investors now owns 7,280,182 shares of the semiconductor company’s stock worth $3,533,526,000 after purchasing an additional 114,893 shares in the last quarter. Price T Rowe Associates Inc. MD raised its holdings in Synopsys by 21.5% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 5,902,696 shares of the semiconductor company’s stock worth $2,864,933,000 after purchasing an additional 1,045,326 shares in the last quarter. Geode Capital Management LLC increased its holdings in Synopsys by 2.3% in the fourth quarter. Geode Capital Management LLC now owns 3,357,165 shares of the semiconductor company’s stock valued at $1,625,230,000 after buying an additional 75,298 shares in the last quarter. Finally, Pictet Asset Management Holding SA increased its holdings in Synopsys by 3.5% in the fourth quarter. Pictet Asset Management Holding SA now owns 1,758,759 shares of the semiconductor company’s stock valued at $853,631,000 after buying an additional 60,121 shares in the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
A number of research analysts have issued reports on the stock. KeyCorp dropped their target price on shares of Synopsys from $690.00 to $555.00 and set an “overweight” rating for the company in a report on Tuesday, April 15th. Needham & Company LLC reaffirmed a “buy” rating and issued a $650.00 target price on shares of Synopsys in a report on Thursday, February 27th. Bank of America dropped their target price on shares of Synopsys from $630.00 to $560.00 and set a “buy” rating for the company in a report on Wednesday, April 16th. Stifel Nicolaus set a $550.00 target price on shares of Synopsys in a report on Monday. Finally, Mizuho lowered their price target on shares of Synopsys from $650.00 to $600.00 and set an “outperform” rating on the stock in a research report on Tuesday, April 15th. One investment analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $613.43.
Synopsys Stock Performance
Shares of NASDAQ SNPS opened at $443.97 on Tuesday. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $624.80. The firm’s 50 day moving average price is $435.52 and its 200 day moving average price is $491.27. The firm has a market cap of $68.65 billion, a P/E ratio of 30.58, a price-to-earnings-growth ratio of 3.23 and a beta of 1.23.
Insider Buying and Selling
In related news, CEO Sassine Ghazi sold 11,366 shares of the stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $463.75, for a total value of $5,270,982.50. Following the transaction, the chief executive officer now directly owns 70,922 shares of the company’s stock, valued at approximately $32,890,077.50. This trade represents a 13.81 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Geus Aart De sold 15,705 shares of the business’s stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $444.42, for a total value of $6,979,616.10. Following the sale, the insider now directly owns 116,671 shares of the company’s stock, valued at approximately $51,850,925.82. This trade represents a 11.86 % decrease in their position. The disclosure for this sale can be found here. 0.62% of the stock is owned by company insiders.
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also
- Five stocks we like better than Synopsys
- Investing in the High PE Growth Stocks
- 3M Stock: 4 Compelling Reasons to Buy, 1 Big Reason to Pass
- Trading Stocks: RSI and Why it’s Useful
- Kroger: This Must-Own Staples Stock Thrives in Every Market
- Profitably Trade Stocks at 52-Week Highs
- Aerospace and Defense Stocks Take Flight After Strong Earnings
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.